+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

RNAi Drug Delivery Market - Global Strategic Business Report - Product Thumbnail Image

RNAi Drug Delivery Market - Global Strategic Business Report

  • Report
  • March 2026
  • 294 Pages
  • Global
From
From
Ebola Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Drugs and Vaccines - Global Strategic Business Report

  • Report
  • March 2026
  • 485 Pages
  • Global
From
From
Translational Regenerative Medicine Market Report 2024-2034 - Product Thumbnail Image

Translational Regenerative Medicine Market Report 2024-2034

  • Report
  • February 2024
  • 270 Pages
  • Global
From
RNA Based Therapeutics and Vaccines Market Report 2022-2032 - Product Thumbnail Image

RNA Based Therapeutics and Vaccines Market Report 2022-2032

  • Report
  • October 2022
  • 213 Pages
  • Global
From
From
Regenerative Medicine Market Report 2023-2033 - Product Thumbnail Image

Regenerative Medicine Market Report 2023-2033

  • Report
  • March 2023
  • 232 Pages
  • Global
From
Fertility Drugs Market Report 2026 - Product Thumbnail Image

Fertility Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Fanconi Anemia Treatment Market - Global Forecast to 2030 - Product Thumbnail Image

Fanconi Anemia Treatment Market - Global Forecast to 2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Loading Indicator